HealthTell™, has raised $26M in new investment according to its latest filing with the SEC and expanded its Clinical Advisory Board with the additions of John Galgiani, M.D., and Chaim Putterman, M.D., as Clinical Advisors.Continue reading
On March 10, 2016, the Pharmaceutical Research and Manufacturers of America (PhRMA) 2016 Annual Meeting, PhRMA president and CEO Stephen J. Ubl announced the association’s policy solutions for delivering innovative treatments to patients.Continue reading
Each month, BIO provides the latest updates, issues and poll data on issues affecting our bioscience industry at the national level. Here’s what happened in February 2016.Continue reading
NuvOx Pharma, a development stage pharmaceutical company based in Tucson, Arizona, beat out 63 other early stage contenders to take the winning spot at Venture Madness 2016.
The BRAIN Center will develop safe, effective and affordable personalized neurotechnologies for diagnostics, restoration, enhancement, and rehabilitation of sensory, motor, affective and cognitive functions. This mission will be pursued by supporting innovative interdisciplinary research across the multiple dimensions of brain function and behavior with the ultimate goal of improving quality of life.
Early Findings of the 50cc SynCardia Heart Indicate That It Fits Underserved Patients – Women & AdolescentsContinue reading
Neurosurgeons at Barrow Neurological Institute in Phoenix are involved with testing the viability of deep brain stimulation (DBS) to treat Alzheimer’s disease, a disorder that currently has few treatment options. Results from the Phase 2 study, reported in the Journal of Neurosurgery on
Dec. 18, 2015, demonstrated the safety of DBS in Alzheimer’s patients.Continue reading
Researchers at Arizona State University’s Biodesign Institute explores an innovative means of investigating membrane proteins produced by a pair of highly pathogenic organisms. The research team showed that DNA-based genetic immunization, using a device known as a gene gun, could successfully express membrane proteins in mice and induce the animals to produce a range of critical antibodies to bacterial and viral targets.
To enable a new era of medicine through research, technology, and policies that empower patients, researchers, and providers to work together toward development of individualized care. (Mission Statement of the White House Precision Medicine Initiative.)Continue reading